Surgical Tumor Removal: Types, Indications & Multidisciplinary Decision-Making
Common Tumors Managed Surgically
| Category | Examples | Typical Surgical Approach |
|---|---|---|
| Benign Soft Tissue | Lipoma, Fibroma, Schwannoma, Hemangioma | Marginal excision, enucleation |
| Benign Glandular | Adenoma (thyroid, parotid, adrenal, pituitary) | Organ-sparing resection / total glandectomy |
| Carcinomas (Epithelial) | Breast, Lung, Colon, Prostate, Thyroid, Renal Cell | Wide local excision ± lymphadenectomy; organ-specific standards (e.g., lumpectomy+SLNB, colectomy, nephrectomy) |
| Sarcomas (Mesenchymal) | Osteosarcoma, Liposarcoma, Leiomyosarcoma, GIST | Wide compartmental resection; neoadjuvant/adjuvant chemo/RT per histology |
| Lymphomas | Hodgkin, Non-Hodgkin (DLBCL, Follicular) | Rarely primary surgery (diagnostic biopsy); systemic therapy mainstay |
| CNS Tumors | Meningioma, Glioma (GBM, Astrocytoma), Metastases | Craniotomy ± awake mapping; gross total resection when feasible |
| Skin Cancers | BCC, SCC, Melanoma | Mohs (BCC/SCC), Wide excision + SLNB (melanoma) |
| Gynecologic | Uterine fibroids (myomectomy/hysterectomy), Ovarian cysts (cystectomy/oophorectomy) | Laparoscopic/hysteroscopic/robotic |
| Thyroid Nodules | Bethesda V/VI, compressive symptoms | Lobectomy vs. total thyroidectomy ± central neck dissection |
When Surgery Is NOT First-Line
- Hematologic malignancies (leukemia, myeloma, most lymphomas)
- Widespread metastatic disease (palliative surgery only for obstruction/fracture)
- Unresectable due to vascular encasement, multifocality, or medical inoperability
- Tumors highly responsive to definitive non-surgical therapy (e.g., anal SCC, nasopharyngeal CA, germ cell tumors)
Multidisciplinary Tumor Board
Standard of care: Surgeon, Medical Oncologist, Radiation Oncologist, Radiologist, Pathologist, Genetic Counselor, Navigator. Decisions integrate stage, biology, patient fitness, and preferences.
Adjuvant & Neoadjuvant Integration
- Neoadjuvant: Downstaging (rectal, esophageal, breast, sarcoma), response assessment.
- Adjuvant: Micrometastatic eradication (chemo, RT, targeted, immunotherapy).
Surgery remains curative cornerstone for localized solid tumors; optimal outcomes require coordinated multimodal planning.
Tumors - Related Articles
- Collarbone Lumps: Causes, Symptoms & When to See a Doctor
- Post-Biopsy Skin Lump: Hematoma or Complications? - Expert Advice
- Neoplasm: Definition, Types, and Benign vs. Malignant Tumors
- Dietary Strategies for Managing Uterine Fibroids: What to Eat & Avoid
- Malignant vs. Benign Tumors: Key Differences & What to Watch For
- Hamster Tumor: Signs, Symptoms & Veterinary Care
- Brachytherapy: Understanding Risks, Benefits & Cancer Types
